🇺🇸 FDA
Pipeline program

225Ac-J591

1706018281

Phase 2 small_molecule active

Quick answer

225Ac-J591 for Prostate Cancer is a Phase 2 program (small_molecule) at UNITED THERAPEUTICS Corp with 2 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Prostate Cancer
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials